Compare Vertiv Holdings Co (VRT) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Vertiv Holdings Co vs State Street SPDR S&P Biotech ETF — how do they compare? Vertiv Holdings Co trades at $305.77 (market cap $112.03B), while State Street SPDR S&P Biotech ETF trades at $154.43. The key difference: Vertiv Holdings Co pays a 0.09% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Vertiv Holdings Co nearer its low. Which is the better fit depends on your goals.
| VRT | XBI | |
|---|---|---|
Market Cap | $112.03B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $376.23 | $164.28 |
52-Week Low | $121.82 | $85.16 |
Enterprise Value | $112.80B | — |
Dividend Yield | 0.09% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Vertiv Holdings Co
Vertiv is a global leader in critical digital infrastructure, providing essential power, cooling, and IT management solutions for data centers, communication networks, and industrial facilities. As the primary provider of advanced thermal management and liquid cooling systems, Vertiv is a central player in the AI revolution, enabling the extreme density and power requirements of next-generation GPU-driven computing.
Read more on VRT →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
